The World Health Organization (WHO) releases its first-ever guidelines on diagnosing and managing type 1 diabetes in adults, focusing on how healthcare systems can improve care and insulin availability. The reports say the guidance targets gaps in access to insulin and essential support for people living with the condition.
Both outlets frame the release as a response to persistent affordability and access challenges, even though insulin was discovered more than a century ago. Vanguard emphasises the guidelines’ purpose alongside an explicit call to make insulin affordable, while The Punch highlights the novelty of the document and its recommendations for daily insulin injection as part of management. With the information available in the provided summaries, the core message is consistent: WHO is setting adult-specific clinical guidance while drawing attention to ongoing barriers to treatment access.
